来源:[1] Tempus宣布与Whitehawk Therapeutics合作推进生物标志物驱动的肿瘤学研究 (https://finance.yahoo.com/news/tempus-announc ...)[2] Tempus宣布与Whitehawk Therapeutics合作推进生物标志物驱动的肿瘤学研究 - Business Wire (https://vertexaisearch.cloud.google.com/groun ...)[3] Whitehawk Therapeutics股价在与Tempus AI合作后飙升 - Investing.com (https://vertexaisearch.cloud.google.com/groun ...)